DK1562573T3 - Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf - Google Patents

Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf

Info

Publication number: DK1562573T3
Authority: DK; Denmark
Prior art keywords: tamsulosin; preparation; pharmaceutical pellets; pellets; pharmaceutical
Prior art date: 2002-11-14

Application number

DK02786241T

Other languages

Danish (da)

English (en)

Inventor

Johannes Jan Platteeuw

Original Assignee

Synthon Bv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-14

Filing date

2002-12-12

Publication date

2006-08-21

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23131212&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1562573(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-12-12 Application filed by Synthon Bv filed Critical Synthon Bv

2006-08-21 Application granted granted Critical

2006-08-21 Publication of DK1562573T3 publication Critical patent/DK1562573T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Inorganic Chemistry (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK02786241T 2002-11-14 2002-12-12 Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf DK1562573T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10/293,940 US7018658B2 (en)	2002-11-14	2002-11-14	Pharmaceutical pellets comprising tamsulosin

Publications (1)

Publication Number	Publication Date
DK1562573T3 true DK1562573T3 (da)	2006-08-21

Family

ID=23131212

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DK02786241T DK1562573T3 (da)	2002-11-14	2002-12-12	Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf
DK200300005U DK200300005U3 (da)	2002-11-14	2003-01-08	Farmaceutiske pellets indeholdende tamsulosin

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
DK200300005U DK200300005U3 (da)	2002-11-14	2003-01-08	Farmaceutiske pellets indeholdende tamsulosin

Country Status (23)

Country	Link
US (1)	US7018658B2 (fr)
EP (1)	EP1562573B1 (fr)
JP (1)	JP5405710B2 (fr)
AT (2)	ATE323478T1 (fr)
AU (3)	AU2002351451A1 (fr)
BE (1)	BE1015435A4 (fr)
CA (1)	CA2415840C (fr)
CH (1)	CH696419A5 (fr)
CZ (1)	CZ13341U1 (fr)
DE (2)	DE60210828T2 (fr)
DK (2)	DK1562573T3 (fr)
ES (1)	ES2257589T3 (fr)
FI (1)	FI5842U1 (fr)
FR (1)	FR2847166B1 (fr)
GB (1)	GB2395125B (fr)
HU (1)	HUP0500832A3 (fr)
NL (1)	NL1022151C2 (fr)
NO (1)	NO20052860L (fr)
PL (1)	PL206083B1 (fr)
PT (1)	PT1562573E (fr)
SI (1)	SI21394A2 (fr)
WO (2)	WO2004043449A1 (fr)
ZA (1)	ZA200503696B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8323692B2 (en)	2002-02-21	2012-12-04	Valeant International Bermuda	Controlled release dosage forms
WO2003072089A1 (fr) *	2002-02-21	2003-09-04	Biovail Laboratories Inc.	Formes posologiques a liberation controlee
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
US7018658B2 (en) *	2002-11-14	2006-03-28	Synthon Bv	Pharmaceutical pellets comprising tamsulosin
EP1638537A1 (fr) *	2003-07-01	2006-03-29	KRKA, tovarna zdravil, d.d., Novo mesto	Noyau de tamsulosine a enrobage de polyvinylpyrrolidone et polyvinylacetate
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20050106253A1 (en) *	2003-11-13	2005-05-19	Platteeuw Johannes J.	Pharmaceutical pellets comprising tamsulosin
WO2005053659A1 (fr) *	2003-12-03	2005-06-16	Natco Pharma Limited	Preparation pharmaceutique amelioree contenant un sel de tamsulosine et procede de fabrication
SI21637A (sl) *	2003-12-23	2005-06-30	LEK farmacevtska dru�ba d.d.	Farmacevtska oblika z nadzorovanim sproščanjem
KR100615952B1 (ko) *	2004-05-27	2006-08-28	한국화학연구원	서방형 약물 전달 시스템
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
SI1618873T1 (sl) *	2004-07-14	2007-10-31	Siegfried Generics Int Ag	Granulat za kontrolirano sproĹˇÄŤanje tamsulozina, ki vsebuje alginat
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
WO2007017253A1 (fr) *	2005-08-10	2007-02-15	Add Advanced Drug Delivery Technologies Ltd.	Preparation orale a liberation controlee d'un benzenesulfonamide
KR20070021806A (ko) *	2005-08-19	2007-02-23	(주)아모레퍼시픽	α1-수용체 차단제의 서방형 펠렛제제 및 이의 제조 방법
KR100745515B1 (ko) *	2006-04-10	2007-08-02	주식회사 대웅제약	염산 탐술로신 함유 서방성 펠렛 및 그의 제조방법
WO2007131804A1 (fr) *	2006-05-17	2007-11-22	Synthon B.V.	Composition en comprimé pour la libération prolongée de la tamsulosine
US20090004284A1 (en) *	2007-06-26	2009-01-01	Watson Pharmaceuticals, Inc.	Controlled release tamsulosin hydrochloride formulation
WO2009047312A1 (fr) *	2007-10-12	2009-04-16	Krka, Tovarna Zdravil, D.D., Novo Mesto	Composition pharmaceutique solide comprenant de la tamsulosine
EP2047847A1 (fr) *	2007-10-12	2009-04-15	KRKA, tovarna zdravil, d.d., Novo mesto	Composition pharmaceutique solide comprenant de la tamsulosine
EP2373297A1 (fr) *	2008-12-09	2011-10-12	Synthon B.V.	Granules de tamsulosine pour une association à dose fixe
US8465770B2 (en) *	2008-12-24	2013-06-18	Synthon Bv	Low dose controlled release tablet
KR20120050975A (ko)	2009-07-22	2012-05-21	그뤼넨탈 게엠베하	산화-민감성 오피오이드를 위한 내변조성 용량형
MX2013002377A (es)	2010-09-02	2013-04-29	Gruenenthal Gmbh	Forma de dosificacion resistente a manipulacion que comprende una sal inorganica.
WO2012110092A1 (fr)	2011-02-17	2012-08-23	Synthon Bv	Dérivés de tamsulosine
DK2736497T3 (da)	2011-07-29	2017-11-13	Gruenenthal Gmbh	Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
PL2736495T3 (pl)	2011-07-29	2018-01-31	Gruenenthal Gmbh	Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
WO2013123965A1 (fr)	2012-02-20	2013-08-29	Synthon Bv	Formulation pharmaceutique à dose fixe
PL2838512T3 (pl)	2012-04-18	2018-12-31	Grünenthal GmbH	Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
WO2014203137A2 (fr)	2013-06-21	2014-12-24	Wockhardt Limited	Compositions pharmaceutiques de tamsulosine ou ses sels
CN105682643B (zh)	2013-07-12	2019-12-13	格吕伦塔尔有限公司	含有乙烯-醋酸乙烯酯聚合物的防篡改剂型
MX371372B (es)	2013-11-26	2020-01-28	Gruenenthal Gmbh	Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
ES2555485T1 (es)	2014-05-26	2016-01-04	Galenicum Health S.L.	Composiciones farmacéuticas que contienen un agente activo
CZ2015225A3 (cs) *	2015-03-30	2016-10-12	Zentiva, K.S.	Nový krok ve způsobu potahování pelet obsahujících Tamsulosin.HCI
CA2998259A1 (fr)	2015-09-10	2017-03-16	Grunenthal Gmbh	Protection contre un surdosage par voie orale a l'aide de formulations a liberation immediate dissuasives d'abus
CN105287395A (zh) *	2015-11-19	2016-02-03	哈尔滨圣吉药业股份有限公司	一种盐酸坦索罗辛缓释微丸及其制备方法
JP2019510071A (ja)	2016-03-31	2019-04-11	ハンミファーマシューティカルズカンパニーリミテッド	安定性及び溶出率が改善されたタダラフィル含有及びタムスロシン含有のカプセル複合製剤
EP3473244A1 (fr)	2017-10-20	2019-04-24	Veru Inc.	Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
EP3473245A1 (fr)	2017-10-20	2019-04-24	Veru Inc.	Chlorhydrate de tamsulosine à libération contrôlée destiné à être administré par voie orale
AU2022374786A1 (en)	2021-10-25	2024-06-13	Farmalíder, S.A.	Tadalafil oral suspension

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS56110665A (en)	1980-02-08	1981-09-01	Yamanouchi Pharmaceut Co Ltd	Sulfamoyl-substituted phenetylamine derivative and its preparation
JPS61100526A (ja) *	1984-10-22	1986-05-19	Kyowa Hakko Kogyo Co Ltd	持続性ドパミン経黒剤
US4772475A (en) *	1985-03-08	1988-09-20	Yamanouchi Pharmaceutical Co., Ltd.	Controlled-release multiple units pharmaceutical formulation
IE60311B1 (en)	1987-09-24	1994-06-29	American Home Prod	Sustained release etodolac
JPH07316077A (ja) *	1994-05-20	1995-12-05	Sumitomo Pharmaceut Co Ltd	腸溶性コーティング用組成物
US6177430B1 (en) *	1997-03-27	2001-01-23	Pfizer Inc	Use of α1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia
DZ2937A1 (fr) *	1998-11-12	2004-03-15	Smithkline Beecham Plc	Compositions nouvelles de sensibilidants à l'insuline.
EP1064938A1 (fr) *	1999-06-28	2001-01-03	Sanofi-Synthelabo	Formes pharmaceutiques à libération contrôlée avec au moins une impulsion temporelle
JP3154710B1 (ja) *	1999-08-09	2001-04-09	山之内製薬株式会社	下部尿路症治療剤
CN1192769C (zh) *	1999-08-09	2005-03-16	山之内制药株式会社	下部尿路症治疗用医药组合物
WO2001015668A1 (fr) *	1999-09-02	2001-03-08	Nostrum Pharmaceuticals, Inc.	Formulation de type pastille a liberation controlee
US6368628B1 (en)	2000-05-26	2002-04-09	Pharma Pass Llc	Sustained release pharmaceutical composition free of food effect
US6287599B1 (en)	2000-12-20	2001-09-11	Shire Laboratories, Inc.	Sustained release pharmaceutical dosage forms with minimized pH dependent dissolution profiles
JP2005512997A (ja) *	2001-11-07	2005-05-12	シントン・ベスローテン・フェンノートシャップ	タムスロシン錠
US7018658B2 (en) *	2002-11-14	2006-03-28	Synthon Bv	Pharmaceutical pellets comprising tamsulosin

2002
- 2002-11-14 US US10/293,940 patent/US7018658B2/en not_active Expired - Lifetime
- 2002-12-12 EP EP02786241A patent/EP1562573B1/fr not_active Revoked
- 2002-12-12 NL NL1022151A patent/NL1022151C2/nl not_active IP Right Cessation
- 2002-12-12 GB GB0229021A patent/GB2395125B/en not_active Expired - Lifetime
- 2002-12-12 WO PCT/NL2002/000821 patent/WO2004043449A1/fr not_active Ceased
- 2002-12-12 HU HU0500832A patent/HUP0500832A3/hu unknown
- 2002-12-12 DK DK02786241T patent/DK1562573T3/da active
- 2002-12-12 AT AT02786241T patent/ATE323478T1/de active
- 2002-12-12 DE DE60210828T patent/DE60210828T2/de not_active Expired - Lifetime
- 2002-12-12 JP JP2004551288A patent/JP5405710B2/ja not_active Expired - Lifetime
- 2002-12-12 DE DE20219293U patent/DE20219293U1/de not_active Ceased
- 2002-12-12 ES ES02786241T patent/ES2257589T3/es not_active Expired - Lifetime
- 2002-12-12 PT PT02786241T patent/PT1562573E/pt unknown
- 2002-12-12 AU AU2002351451A patent/AU2002351451A1/en not_active Abandoned
- 2002-12-16 FI FI20020500U patent/FI5842U1/fi active
- 2002-12-17 CZ CZ200213764U patent/CZ13341U1/cs not_active IP Right Cessation
- 2002-12-18 PL PL357856A patent/PL206083B1/pl unknown
- 2002-12-27 SI SI200200319A patent/SI21394A2/sl unknown
- 2002-12-30 CH CH02222/02A patent/CH696419A5/de not_active IP Right Cessation
2003
- 2003-01-02 AT AT0000203U patent/AT6542U1/de not_active IP Right Cessation
- 2003-01-08 DK DK200300005U patent/DK200300005U3/da active
- 2003-01-08 CA CA002415840A patent/CA2415840C/fr not_active Expired - Lifetime
- 2003-01-09 AU AU2003200059A patent/AU2003200059B2/en not_active Expired
- 2003-01-22 FR FR0300651A patent/FR2847166B1/fr not_active Expired - Lifetime
- 2003-03-24 BE BE2003/0184A patent/BE1015435A4/nl not_active IP Right Cessation
- 2003-11-13 AU AU2003288083A patent/AU2003288083A1/en not_active Abandoned
- 2003-11-13 WO PCT/EP2003/012829 patent/WO2004043448A1/fr not_active Ceased
2005
- 2005-05-09 ZA ZA200503696A patent/ZA200503696B/en unknown
- 2005-06-13 NO NO20052860A patent/NO20052860L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
DE60210828T2 (de)	2006-10-19
AU2003200059B2 (en)	2008-07-03
AU2003288083A1 (en)	2004-06-03
PL357856A1 (en)	2004-05-17
GB2395125B (en)	2007-06-06
US7018658B2 (en)	2006-03-28
NL1022151C2 (nl)	2004-05-18
HUP0500832A2 (en)	2007-07-30
PT1562573E (pt)	2006-07-31
CH696419A5 (de)	2007-06-15
CA2415840A1 (fr)	2004-05-14
NO20052860L (no)	2005-08-10
SI21394A2 (sl)	2004-06-30
JP5405710B2 (ja)	2014-02-05
US20040096502A1 (en)	2004-05-20
AU2003200059A1 (en)	2004-06-03
ATE323478T1 (de)	2006-05-15
CA2415840C (fr)	2008-11-18
FR2847166A1 (fr)	2004-05-21
GB0229021D0 (en)	2003-01-15
DE20219293U1 (de)	2003-06-05
FI5842U1 (fi)	2003-07-03
HUP0500832A3 (en)	2009-12-28
EP1562573A1 (fr)	2005-08-17
PL206083B1 (pl)	2010-06-30
JP2006508960A (ja)	2006-03-16
NO20052860D0 (no)	2005-06-13
DE60210828D1 (de)	2006-05-24
AU2002351451A1 (en)	2004-06-03
FIU20020500U0 (fi)	2002-12-16
WO2004043448A1 (fr)	2004-05-27
FR2847166B1 (fr)	2005-06-10
ES2257589T3 (es)	2006-08-01
WO2004043449A1 (fr)	2004-05-27
GB2395125A (en)	2004-05-19
AT6542U1 (de)	2003-12-29
DK200300005U3 (da)	2003-04-25
CZ13341U1 (cs)	2003-06-02
ZA200503696B (en)	2006-08-30
BE1015435A4 (nl)	2005-04-05
EP1562573B1 (fr)	2006-04-19

Publication	Publication Date	Title
DK1562573T3 (da)	2006-08-21	Farmaceutiske pellets omfattende tamsulosin og en fremgangsmåde til fremstilling deraf
DK1480622T3 (da)	2009-02-16	Farmaceutiske, granulære immediate release-præparater og en kontinuert fremgangsmåde til fremstilling deraf
DK1534237T3 (da)	2009-05-04	Oralt oplöselige tabletter og fremgangsmåde til fremstilling deraf
NO20031776L (no)	2003-10-20	Null-boringskomplettering og produksjonssystem
KR20050009999A (ko)	2005-01-26	약제학적 제제
DK1467712T4 (da)	2011-11-21	Fremgangsmåde til at fremstille en tolags farmaceutisk tablet omfattende telmisartan og hydrochlorthiazid
IS7948A (is)	2005-07-20	Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
DK1753406T4 (da)	2019-11-04	Overtrukket tabletformulering og fremgangsmåde
DK1509266T3 (da)	2009-10-19	System omfattende en dyse og et holdersystem
DE60210315D1 (de)	2006-05-18	Tamsulosin tabletten
IS7369A (is)	2004-07-23	Aðferð og tæki til örflögunýmyndunar
DK1589825T3 (da)	2007-12-17	Komprimeret tyggegummitablet
IS7594A (is)	2004-12-13	Laxófoxifen tafla og húðun hennar
ATE388693T1 (de)	2008-03-15	Wohlschmeckende kautablette
DK1560826T3 (da)	2006-08-14	Pyridopyrimidinonderivater, fremgangsmåde til fremstiling heraf og farmaceutiske sammensætninger indeholdende disse
NO20055173D0 (no)	2005-11-03	Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
NO20043333L (no)	2004-09-13	Farmasoytiske parvastatinformuleringer og fremgangsmater for anvendelse av dem
IS7266A (is)	2004-05-14	Lyfjaform sem innihalda sýru-óþolin virk efni og aðferðir til tilreiðslu þeirra
IS7798A (is)	2005-04-11	Efnasambönd, lyfjablöndur og aðferðir
ATE434435T1 (de)	2009-07-15	Pharmazeutische zubereitungen enthaltend modafinil
NO20042890L (no)	2004-07-07	Farmasoytiske preparater og fremgangsmate for fremstilling derav
DK1849468T3 (da)	2013-02-04	Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
DK1572950T3 (da)	2013-02-04	Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
DK1639107T3 (da)	2013-11-18	Forbedrede proteaser og fremgangsmåder til fremstilling deraf
IS7846A (is)	2005-05-13	Aðferð til að framleiða lyfjafræðilega virkt efnasamband og til að framleiða milliefni þess